Business
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT), a surgical robotics global leader, is pleased to announce
About this update from Procept Biorobotics Corporation
[{"type":"text","content":"SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT), a surgical robotics global leader, is pleased to announce that the National Institute for Health and Care Excellence (NICE) has bestowed its strongest endorsement, the \"standard arrangements\" recommendation, on Aquablation® therapy for the treatment of benign prostatic hyperplasia (BPH). NICE plays a pivotal role in providing guidance to enhance health and social care in the United Kingdom. For a procedure to secure such a recommendation, it must demonstrate both short-term and long-term safety and efficacy. NICE’s endorsement underscores that the robotically assisted Aquablation therapy meets these rigorous standards. \"Aquablation therapy has consistently shown itself to be a reliable and safe robotic treatment for BPH over the years,” said Dr Neil Barber, Clinical Lead of Urology, Frimley Health NHS Foundation Trust and Director of the Frimley Benign Prostate Clinical Research Centre. “Garnering the premier evidence-based recommendation from NICE not only raises the standard of care for urologists in the UK but also serves as a strong catalyst for its broader adoption. We've witnessed countless men whose lives have been dramatically improved by this treatment, evident from our growing waiting list of those opting for Aquablation therapy over other solutions.\" \"After an extensive multi-year evaluation, we're elated to share that Aquablation therapy has received the top-tier recommendation from NICE,” said Sham Shiblaq, Executive Vice President and Chief Commercial Officer of PROCEPT BioRobotics. “Although NICE's purview is the UK, its clinical endorsements have significant international influence. This bolsters our conviction that Aquablation therapy is on course to be the global standard of care for BPH.\" About Aquablation TherapyAquablation therapy is the first and only image-guided, robotically assisted, heat-free water jet for the treatment of BPH. The system’s real-time ultrasound imaging provides the surgeon with a multi-dimensional view of the prostate enabling personalized treatment planning tailored to each patient’s unique anatomy. The surgeon can specify which areas of the prostate to remove while preserving the anatomy that controls erectile function, ejaculatory function, and continence. Once the treatment pla...